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Summary: A solid-phase radioimmunoassay was developed for measuring the concentration of antispermato-
zoa antibodies in the sera of sterile patients. Whole human spermatozoa fixed in methanol and immobilized
on plastic microtiter plates were used äs antigens, and the spermatozoa-bound antibodies were quantitated
with the aid of [125I]protein-A. The assay is specific, simple to perform and up to 1000 tests can be carried out
conveniently by one technician on a single working day. The new test was shown to correlate better with
immunological sterility than the sperm microagglutination and immobilisation tests. An antispermatozoa anti-
body concentration of 210 g/l and above was found be indicative of an immunological cause of infertility.
Bestimmung der Konzentration gegen Humanspermatozoen gerichteter Antikörper in Seren steriler Patienten
durch einen [I25I] Protein-A Immunsorbent-Test
Zusammenfassung: Es wurde ein Festphasen Immunsorbent-Test für die Bestimmung der Konzentration
gegen Humanspermatozoen gerichteter Antikörper in Seren steriler Patienten entwickelt. Fixierte intakte
menschliche Spermatozoen, die auf Mikrotiterplatten aufgetragen sind, dienen als Antigene. Die an die Sper-
mien gebundenen Antikörper werden durch 125Iod-markiertes Protein- indiziert. Dieses Testverfahren ist
einfach durchzuführen, und es können bis zu 1000 Bestimmungen von einer technischen Assistentin an einem
Tag durchgeführt werden. Der neue Test zeigt eine bessere Korrelation mit anhaltender Sterilität als die
üblichen Mikroagglutinations- und Mikroimmobilisationstests für Spermien. Eine Konzentration gegen Hu-
mansperma gerichteter Antikörper von 210 g/l deutet auf eine immunologisch bedingte Sterilitätsursache
hin.
Introduction
Several methods have been described for the detec-
tion of antispermatozoa antibodies (l--5), Most of
these tests rely on judgements of observation. In ad-
dition some are known to be adversely effected un-
specifically by e. g, hormones or drugs present in the
serum of the patient (6). None of the presently used
tests can quantitate the antispermatozoa antibody
concentrations in the sera.
In this paper we report the development of a new
solid-phase protein-A binding assay that permits the
estimation of antispermatozoa antibody concentra-
tions in g/l. Bacterial protein-A (Staph. aureus) is
known to bind specifically to the Fc portion of IgG
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molecules in a liumber of species, including man (7).
The binding to human IgG is restricted to the IgGi,
IgG2 and IgG4 subclasses.
This property of the protein-A molecule has been




Protein- (Staph. aureus, Cowan strain) with an IgG binding ca-
pacity of 11 mg/mg was obtained from Sigma Chem., Munich
FRG.
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Radio iod ina t ion of protein-A
The radioiodinating reagent N-3-(4-hydroxy-3,5-diiodo-
phenyl)propionyloxy succinimide (148 TBq/mmol) (Bolton-Hun-
ter Reagent) was purchased from New England Nuclear, Dreieich
FRG. In a typical labelling experiment 11.1 MBq of the Bolton-
Hunter reagent and 5 μg of the protein-A were incubated in 0.01
mol/1 phosphate buffer, pH 8.0 for 30 min at 0 °C and for 24 h at
4 °C. The prolonged incubation ensures that all the ester groups
are either conjugated or hydrolysed (11). This obviates the need
for Inhibition by addition of an amino acid mixture. Following the
incubation the [125I)protein-A was purified on a Sephadex-G 25
column. The column was equilibrated and eluted with a 0.01 mol/1
phosphate buffer pH 7.2, containing l g/l gelatin. One ml frac-
tions were collected and the first radioactive peak fraction was
aliquoted into 100 μΐ portions. The aliquots were kept at ---20 °C
until use.
Purif icat ion of antispermatozoa IgG
Different volumes of sera from sterile patients were pooled to give
ca. 100 ml and dialyzed against 0.05 mol/1 Tris-HCl buffer pH 6.5
for 72 hours at 4 °C. The spermagglutinating titer of the pooled
serum was estimated before dialysis and was found to be positive
at l : 512 dilution. The dialysed serum was then applied to a die-
thylaminoethylcellulose column (1.8x50 cm), which had been
previously equilibraied with the above starting buffer. Elution
commenced with a linear gradient of 0.1—1 mol/1 NaCl with the
same buffer. Ten ml fractions were collected at a flow rate of
l .5 ml/h. The fractions in the first peak were tested for purity by
radial immunodiffusion and used in the solid-phase assay at a pro-
tein concentration of 100 mg/1 (see below).
Preparation of the microtiter plates
wi th target cell antigens
Spermatozoa from healthy donors, with normal spermiogram and
an average sperm count of 2.5 x 1010/1, were washed three times
in 0.06 mol/1 phosphate buffer in 0.15 mol/1 NaCl pH 7.2 at 600 g
for 10 min at 4 °C.
After the final centrifugation the cells were resuspended in the
above buffer at a concentration of 3 x 109/1. The cell Suspension
was then distributed in 100 μΐ portions into the U-bottom wells of
microtiter plates (Dynatech Laboratories Inc., Massachusetts,
U.S.A.). The plates were then centrifuged at 150g for 10 min,
4 °C and the supernatants decanted. Approximately 100 μΐ of me-
thanol was added to each well and the plates were centrifuged for
another 10 min. After removal of the supernatants the rest of the
methanol was allowed to evaporate. The attached cells were
washed three times with 200 μΐ of cold phosphate-buffered saline.
The plates were then incubated for 15 min at room temperature in
a phosphate buffered saline, containing l g/l bovine serum albu-
min and 0.5 ml/l Tween- 20 and stored at -20 °C until use. Only
wells with monolayers of spermatozoa were used for the assays.
Assay val idat ion
Coating the microtiter plates at different t rgel cell c ncentrations
Various c ncentrations of spermatozoa were tried in order to es-
tablish optimal assay conditions. The wells were coated with
3 x 102, 3 x 103, 3 x 104, 3 x 105 and 3 x 106 spermatozoa. The
solid-phase assay was performed s described, using the purified
antispermatozoal IgG fraction at a concentration of 200 \ig/[.
Nonspecific binding was calculated by substituting the IgG with
0.06 mol/1 phosphate buffer pH 7.2 in 0.15 mol/1 NaCl.
Estimation of spermatozoa-bo nd antibody concentration with the
purified antispermatozoa IgG
The peak IgG fraction (number 19) was diluted to contain 2000,
200,20 and 2 μg/l IgG with 0.06 mol/1 phosphate buffer pH 7.2 in
0.15 mol/1 NaCl, and assayed in the solid-phase assay. The condi-
tions for the solid-phase assay were the same s described above.
The specific activity of [125I]protein-A was calculated from the
Inhibition assay (see below). For the estimation of spermatozoa-
bound IgG, the q antity of bound [125I]pfotein-A (in ng) was
multiplied by the binding capacity e. g. 11. Vafio s phosphate buf-
fers with the same ionic strength but different pH (6.5, 7.0, 7.2,
7.5) were tested in order to achieve optimal [l25I]protein-A bind-
ing.
Inhibition of [I25IJprotein-A binding with cold protein-A in the
solid'phase assay
A 200 \ig/[ solution of the purified antispermatozoa IgG fraction
was used in the assay. Increasing c ncentrations of cold protein-
A, from 0.25, 50,100,150, and 200 ̂ g/l were added to [I25Ii)prq-
tein-A (5.38 KBq), and the amount (ng) ofbpund [125I]prptein-A
on the spermatozoa-antibody complex was estimated at 0.5 Inhi-
bition of total binding.
Adsorption of antispermatozoa antibodies with unfixed human
spermatozoa
In order to check whether the spermatozoal membrane antigens
are affected by methanol fixation, and t establish specificity, the
purified antispermatozoa IgG was adsorbed with fresh human
spermatozoa. One hundred microliters of diluted IgG, l: 5000 in
0.06 mol/1 phosphate buffer pH 7.2 containing 0.15 mol/ί NaCl,
was incubated with l O7 washed spermatozoa at a spermatozoa
concentration of 10! */l for 24 h at 4 °C. Following the incubation
the mixture was centrifuged at 6000 g for 30 min and the supef-
natant was incubated again with new spermatozoa under the same
conditions.
This process was repeated twice and finally the supernatant as-
sayed in the solid-phase test.
Adsoφtion of the positive control serum (see quality control) was
done similarly, except that the incubation'was repeated only once.
Solid-phase-protein-A binding assay
In the routine assays of patient sera the sera were diluted l : 4
with 0.06 mol/1 phosphate buffer pH 7.2 in 0.15 mol/1 NaCl. One
hundred microliters of the diluted sera were pipetted into the mi-
crotiter wells and the plates were incubated for 60 min at 25 °C
and for 60min at 4°C. Following the incubation the wells were
rinsed three times with the ice cold buffer, and 100 μΐ of [125I]pro-
tein-A (1.11 kBq) was added to eaeh well. This was followed by
another incubation of 60 min at 4 °C. At the end of the incubation
the wells were rinsed again with the same buffer and the plastic
wells were cut out. Each of the cut out wells was put into a plastic
tube (20 x 160 mm) and these were counted in a BF 5000 61 γ-
counter for l min each.
Quality control
For an acc rate calculati n of the specific activities of [125I]pro-
tein-A at a given time, the isotope decay chart of 125I was used.
The BF 5000 G l γ-counter was calibrated using a simulated 125I
radiation source Standard (129I nuclide in propylene RIA-tube,
370 Bq. New England Nuclear, Dreieich FRG). Kabbit antihu-
man-spermatozoa antisemm diluted l: 4 in 0.06 mol/1 phosphate
buffer (Behringwerke, Marburg/Lahn, FRG) was used routineiy
with each set of patient sera to maintain quality control of the
coated plates, [125I]protein-A binding arid assay conditions.
Only control sera that showed a total {12*i]protein-A binding of
0.65 (± 0.05) were used for quality control.
J. Clin. Chem. Clin. Biochem. / Vol. 21, 1983 / No. 6
Czuppon and Mettler: Estimation of anti-spermatozoa antibody concentrations in sera of infertile patients 359
Test sera
The sera of sterile patients were sent to our laboratory for routine
diagnosis of antispermatozoa antibodies. All patients had wanted
children for at least one year and no other clinical tests could ex-
plain their persistent infertility.
A group of fertile couples, i. e. last child born within the past two
years, served s negative controls. The groups included husbands
or wives or both.
Sperm-micro-agglutination and immobil isat ion tests
The microscopic tests of sperm-agglutination and sperm-immobil-





Radioiodination of protein-A resulted in specific ac-
tivities of 222 to 296 kBq/ng protein-A. Keeping
the labelled product at —20 °C for up to three weeks
had no significant effect on the sensitivity of the im-
munoassay, when the aliquots were stored with gela-
tine carrier and the samples were thawed only once.
In this study, protein-A with an IgG binding capacity
of 11 nag/mg was used throughout. The assay sensi-
tivity and reproducibility was not effected when pro-
tein-A with lower binding capacities were tried, but
allowances had to be made in calculating the bound
IgG concentrations.
The pH of the reaction mixture seems to be an im-
portant factor, probably because of the pH depend-
ence of protein-A binding to the IgG subclasses
(12). The assay seems to be optimal at pH 7.2 and
this is achieved conveniently by use of phosphate
buffered saline.
Various concentrations of the spermatozoa target
cells (antigen) showed that under the conditions de-
scribed maximal binding occurs at 3 x l O5 spermato-
zpa per well (fig. 1). Higher cell concentrations re-
sulted in multi layers of the coated cells witho t sig-
nificant elevation of antibody binding. Therefofe a
cell concentration of 3 Χ 105 per well was chosen for
all assays.
The linearity of the antibody concentration deter-
mined against spermatozoa with the logz titer of rab-
bit antihuman spermatozoa antiserum is shown in
figure2. A correlation coefficient of r == 0.989 was
obtained, while the C.V. of interassay Variation was
0.08%. Day to day Variation of the control serurn
was estimated to be ^0.1 over a period of one year.
Non specific binding with normal serum amounted








Fig. 1. Dependence of the concentration of bound [125I)protein-
A on the number of target cells. The plates were coated
with increasing numbers of spermatozoa (Δ 0.3 · l Ο3; χ 3 ·
ΙΟ3; D 30 · 103; D 300 - 103; A 3000 - 103) and purified
antispermazotoa IgG was used s antiserum. The assay
was carried out s described in Materials and Methods. A
spermatozoa concentration of 3 · l O5 per well was chosen
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Fig. 2. A typical calibration curve of the solid-phase immunoas-
say with [125I]proteinrA and the positive control serum
(Behring Werke). Values represent mean ± 2 χ S.D. (x)
serially diluted positive control serum; arrow at left =
negative levels following adsorption of the positive control
serum with fresh, unfixed human spermatozoa (Π); non-
immune rabbit serum (A).
The specificity of the solid-phase immuno assay is
demonstrated by the fact that absorption of the con-
trol serum with unfixed, fresh spermatozoa, prior to
the assay, resulted in negative antibody levels
(fig. 2). Similar results were obtained using normal
rabbit serum.
DEAE-cellulose affinity chromatography of the
pooled patient sera showed an IgG peak in fractions
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13—21. Fraction 19 was found to contain the highest
anti-spermatozoa antibody concentration. The solid-
phase immunoassay with that fraction (fig. 3) indi-
cated maximal protein-A binding at concentrations
of 20 μg/l and above. The specificity of [125I]protein-
A binding is indicated by the fact that the reaction
can be inhibited quantitatively by unlabelled pro-
tein-A (fig. 4). A 0.5 Inhibition is obtained with
2.1 ng of cold protein-A. This was not significantly





Fig. 3. Solid-phase immunoassay with purified antispermatozoa
IgG from pooled sterile patient sera of various dilutions.
The spermatozoa-bound IgG concentrations were calcu-
lated using the specific activity of the [125I]protein-A and
an IgG binding capacity of 11 mg/mg protein-A (see
Material and Methods). Maximal protein-A binding was
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Fig. 4. Quantitative Inhibition of the [125I]protein-A by unla-
belled protein-A in the solid phase immunoassay. The
value obtained at 0.5 binding (2.1 rig) was not significantly
different from that of 1.95 ng, calculated from the specific
activity of [125I]protein-A alone.
The positive control serum, rabbit antihuman sper-
matozoa antiserum was found to have an average an-
tispermatozoa antibody concentration of 1122μg/l
(± 102). Normal rabbit serum showed antibody lev-
els of 41 μg/l, (±12); and the antibody concentra-
tion of rabbit antiserum was reduq^d from 1122 μg/l
to 57 [ig/l (±16.6) by adsorptioii with human sper-
matozoa (tab. 1).
The routine assay of the sera of patients revealed a
wide r nge of antispermatozoa antibody concentra-
tions from s low s 54 μg/ί to s high s 1098 μg/l.
There was also an increasing tendency fof an elevat-
ed antispermatozoa antibody concentration with
progressive years of persistent i fertility in these
groups. The average antispermatozoa antibody con-
centration ranged from 472 μg/l with patients of one
year of wanting pregnancy to 717 μg/l for one pa-
tient with a history of 16 years of sterility (tab. 2).
A comparison of the antibody concentrations in the
solid-phase assay with the sperm microagglutination
and immobilisation tests in sera of a randomly select-
ed subpopulatipn of sterile patients (tab. 2) indic tes
a significant disagreement between the two type of
tests. Oiily about 15% of the sera in the infertile
groups was also positive in the sperm microaggl ti-
nation/immobilisatioii tests. In these positive sera
there was no correlation betweeij the titers in the
sperm agglutination/immobilisation and antisperma-
tozoa antibody concentrations in the solid-phase as-
say. One ser iii, for example, with an antibody con-
centration of 1098 μg/l was still negative in the
sperm microagglutination arid immobilisation tests.
Tab. 1. Res lts of the routine quality control of the solid-phase
[125I]protein-A binding assay during evaluation of the
patient sera. The positive control serum rabbit antihuman
spermatozoa antiserum was incl ded with each set of



























l) == mean and r nge of IgG concentrations indicated.
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On the other band two of the patients with proven
fertility and an antispermatozoal antibody concen-
tration of äs low äs 200 ^ had a positive titer 1:16
in the sperm microagglutination test. Additional
false positives of 1:4 to 1:8 were found in the fertile
group (tab. 1). In the group of patients with proven
fertility the average non-specific antibody concen-
tration was found to be 166 §/1 by the solid-phase
assay. This was significantly lower than the antibody
concentrations in all the sterility groups (Studenfs t-
test, p < 0.05).
Discussion
Radioiodinated protein-A has been used previously
to quantitate IgG in various solid and liquid phase
immunoassays (8, 9). As shown previously, the pre-
dominant Ig class in sera of sterile patients is IgG
(13). Furthermore, there is a subclass of antisperma-
tozoa IgG antibodies, which is present naturally in
sera, and which reacts with staphylococcal protein-A
(10). Taking these facts into consideration, a solid-
phase [125I]protein-A binding assay was developed
that is relativeiy simple to perform and is specific for
detection of antispermatozoa antibodies in immune
sera. In addition, under carefully controlled assay
conditions, the direct estimation of antispermatozoa
Tab. 2. Solid-phase [125I]protein-A binding assay of antisperma-
tozoa IgG in sera of patients with progressive years of
persistent infertility. The comparison with sperm
microagglutination and sperm microimmobilisation is
shown in the last column. The mean antispermatozoa IgG
concentration of the infertile group was estimated to be
494 g/l compared to the fertile group of 166 g/l (see
































































= Values represent mean IgG concentration and ränge. All
assay were done in triplicate.
antibody concentration is possible, for which no
other tests are available at present. For adequate
quality control the specific activity of the radioiodi-
nated protein-A should be accurately estimated and
day to day corrections should be made with the aid
of the 12SI decay chart.
Where a uniformity of the labelling procedure with
regard to specific activity, radiochemical purity etc.,
cannot be safeguarded, a simple Inhibition assay with
cold protein-A can be set up to estimate bound
[125I]protein-A in ng. Alternatively, radioiodinated
protein-A preparations that are available commer-
cially can also be used.
There is no need to use purified human antispermat-
ozoal IgG for a calibration Standard. It was used in
the present work only for initial assay validation
tests. A rigorous quality control can also be main-
tained with a polyvalent positive control serum,
which is also available commercially. However, since
there may be variations in the antispermatozoa anti-
body concentrations in the various batches, either
the same lot numbers should be used or adjustments
made with regard to total protein-A binding. A good
positive control serum should give 0.6—0.7 of total
binding of [125I]protein-A under the assay condi-
tions.
Similarly there could be some variations in the (hy-
drophobic) properties of the plastic surface of the
microtiter plates that are supplied by the different
manufacturers. In our laboratory the plates from
Dynatech Co. proved to be of best quality, with re-
gard to reproducibility. The coated plates with sper-
matozoa can be stored desiccated for prolonged pe-
riods ät —20 °C, without affecting the assay repro-
ducibility. The quality of spermatozoa that are used
for coating seems to be of lesser importance. In these
tests fresh spermatozoa from healthy donors with a
normal spermiogram were used throughout. Howev-
er we also tried coating the plates with spermatozoa
that were stored at — 20 °C for up to six months,
without adverse effects on the assay. The possibility
of using soluble spermatozoal antigens in the solid-
phase assay is being iiivestigated at present. The cor-
relation of the antispermatozoa antibody concentra-
tion, estimated by the solid-phase assay, with unex-
plained persistent infertility could provide a useful
diagnostic test in cases of functional disturbances of
fertility.
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